| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 54 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 160.7K | $9.22M | - | |
| CEO | 133.2K | $7.64M | -18,198 | |
| CFO | 106.5K | $6.11M | - | |
| Other | 76.8K | $4.40M | -17,000 | |
| VP | 29.0K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 7,098 | $109.21 | $775,154.41 | -0.6% | -20.7% | -61.4% | |
| Oct 7, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $109.27 | $546,352.55 | -3.2% | -20.7% | -61.4% | |
| Oct 1, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 55,000 | $114.25 | $6,283,860.79 | -1.3% | -29.0% | -67.1% | |
| Oct 1, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $114.24 | $913,917.45 | -1.3% | -29.0% | -67.1% | |
| Oct 1, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,500 | $114.24 | $628,294.76 | -5.7% | -29.0% | -67.1% | |
| Sep 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $115.94 | $927,550.51 | -2.8% | -22.9% | -72.0% | |
| Sep 17, 2024 | Loxam Teri | Director | Sale+OE | 6,250 | $116.28 | $726,730.95 | -13.7% | -23.3% | -73.5% | |
| Sep 16, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 10,000 | $115.96 | $1,159,634.91 | -1.6% | -21.7% | -72.7% | |
| Sep 3, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 10,000 | $111.93 | $1,119,251.67 | -0.5% | -16.8% | -70.9% | |
| Sep 3, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $112.11 | $186,879.52 | -0.8% | -16.8% | -70.9% |